BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21617717)

  • 1. Absence of paxillin gene mutation in lung cancer and other common solid cancers.
    Kim MS; Yoo NJ; Lee SH
    Tumori; 2011; 97(2):211-3. PubMed ID: 21617717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and expressional analyses of MYD88 gene in common solid cancers.
    Je EM; Kim SS; Yoo NJ; Lee SH
    Tumori; 2012; 98(5):663-9. PubMed ID: 23235763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
    Kim MS; Jeong EG; Yoo NJ; Lee SH
    Br J Cancer; 2008 May; 98(9):1533-5. PubMed ID: 18392055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.
    Pallier K; Houllier AM; Le Corre D; Cazes A; Laurent-Puig P; Blons H
    Mol Carcinog; 2009 Jul; 48(7):581-5. PubMed ID: 19353596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
    Yoo NJ; Park SW; Lee SH
    Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare somatic mutation of pro-apoptotic BAX and BAK genes in common human cancers.
    Kim MS; Kim SS; Yoo NJ; Lee SH
    Tumori; 2012 Nov; 98(6):149e-51e. PubMed ID: 23389372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.
    Kawada I; Hasina R; Lennon FE; Bindokas VP; Usatyuk P; Tan YH; Krishnaswamy S; Arif Q; Carey G; Hseu RD; Robinson M; Tretiakova M; Brand TM; Iida M; Ferguson MK; Wheeler DL; Husain AN; Natarajan V; Vokes EE; Singleton PA; Salgia R
    Cancer Biol Ther; 2013 Jul; 14(7):679-91. PubMed ID: 23792636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of caspase-14 gene in common carcinomas.
    Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
    Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.
    Oh JE; Kim MS; Ahn CH; Kim SS; Han JY; Lee SH; Yoo NJ
    Pathology; 2010 Jan; 42(1):73-6. PubMed ID: 20025484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of proapoptotic integrin beta 3 cytoplasmic domain in common human cancers.
    Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
    Tumori; 2007; 93(3):281-3. PubMed ID: 17679464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
    Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutation of PINX1 gene is rare in common solid cancers.
    Kim MS; Kim SS; Yoo NJ; Lee SH
    APMIS; 2012 Sep; 120(9):770-1. PubMed ID: 22882268
    [No Abstract]   [Full Text] [Related]  

  • 13. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
    Wu DW; Cheng YW; Wang J; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of UBR5 gene encoding an E3 ubiquitin ligase in common human cancers.
    Kim MS; Oh JE; Eom HS; Yoo NJ; Lee SH
    Pathology; 2010 Jan; 42(1):93-4. PubMed ID: 20025491
    [No Abstract]   [Full Text] [Related]  

  • 15. ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
    Wang Y; Ding X; Liu B; Li M; Chang Y; Shen H; Xie SM; Xing L; Li Y
    Mol Carcinog; 2020 Jan; 59(1):73-86. PubMed ID: 31670855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of proapoptotic ARTS P-loop domain in common human cancers.
    Lee JW; Soung YH; Young Kim S; Woo Nam S; Sang Park W; Young Lee J; Jin Yoo N; Lee SH
    Pathol Res Pract; 2006; 202(2):67-70. PubMed ID: 16376484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.
    Vatan O; Bilaloglu R; Tunca B; Cecener G; Gebitekin C; Egeli U; Yakut T; Urer N
    Tumori; 2007; 93(5):473-7. PubMed ID: 18038880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
    Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
    Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutation of SPOP tumor suppressor gene is rare in breast, lung, liver cancers, and acute leukemias.
    Kim MS; Kim MS; Yoo NJ; Lee SH
    APMIS; 2014 Feb; 122(2):164-6. PubMed ID: 23654205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.